跳至主要内容
临床试验/CTRI/2021/03/031616
CTRI/2021/03/031616进行中(未招募)未知

Evaluating the Use of Flavour-Stimulated Oral Fluids Collection for Severe Acute Respiratory Syndrome Coronavirus 2 Detection by Reverse Transcriptase Polymerase Chain Reaction and Enzyme Linked Immunosorbent Assay - a Concordance Study.

Datar Cancer Genetics0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Known COVID-19 positive by RTPCR (with active infection)
  • Known COVID-19 negative by RTPCR (tested within 7 days)
  • 2. Provision of Informed Consent
  • 3. Willing to provide Nasopharyngeal Swab as well as Buccal Cavity Swab

排除标准

  • 1. Pediatric patients.
  • 2. Inability to provide Informed Consent.
  • 3. Inability to provide Nasopharyngeal Swab and / or Buccal Cavity Swab.
  • 4. Other conditions: allergic to latex.
  • 5. Diagnosed with psychological conditions that restrict ability to comply with study procedures;
  • 6. Prisoners and pregnant women
  • 7. Subjects with pathologies relating to dental, oral and salivary conditions.
  • 8. Subjects with allergies related to the components used in the kit.
  • 9. Any other condition as judged by the PI which will restrict the ability to participate in the study and / or comply with study procedures.

研究者

发起方
Datar Cancer Genetics

相似试验